milrinone has been researched along with lactic acid in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Binah, O; Danilo, P; Rosen, M; Sodowick, B; Vulliemoz, Y | 1 |
| Katz, S; LeJemtel, TH; Scortichini, D | 1 |
| Andersen, LW; Baek, L; Doolan, L; Liu, G; McNicol, L | 1 |
| Akbary, A; Atz, AM; Bailey, JM; Chang, AC; Hoffman, TM; Kaczmarek, R; Kocsis, JF; Kulik, TJ; Nelson, DP; Spray, TL; Wernovsky, G; Wessel, DL | 1 |
| Kirby, DS; Lobato, EB; Muehlschlegel, JD; Muehschlegel, JD; Sidi, A | 1 |
| Gerolioliou, K; Papakonstantinou, C; Spanos, P; Tatlis, A; Toumbouras, M | 1 |
| Kirby, DS; Lobato, EB; Muehlschlegel, JD; Sidi, A | 1 |
| Bigam, DL; Charrois, G; Cheung, PY; Jewell, LD; Joynt, C; Korbutt, G | 1 |
| Funakubo, A; Hanita, T; Kitanishi, R; Matsuda, T; Miura, Y; Saito, M; Watanabe, S | 1 |
| Freeman, D; McNamara, PJ; Sahni, M; Shivananda, SP; Taddio, A | 1 |
| Bøtker, HE; Colding, PD; Hyldebrandt, JA; Kolstrup, LM; Ravn, HB; Schmidt, MR | 1 |
| Anetseder, M; Johannsen, S; Roewer, N; Schuster, F | 1 |
| Al Kindi, H; Nepotchatykh, O; Paul, A; Prakash, S; Schwertani, A; Shum-Tim, D; You, Z | 1 |
| Camacho, E; Jemielity, M; Ligowski, M; Straburzyńska-Migaj, E; Tomczyk, J; Urbanowicz, T; Walczak, M | 1 |
| Almodovar, MC; Baird, CW; Bond, HC; DiNardo, JA; Emani, SE; Ford, M; Kaza, AK; Kheir, JN; Mills, KI; Pigula, FA; Quinonez, LG; Thiagarajan, RR; Walsh, BK; Wypij, D | 1 |
| de Waal, K; Phad, N | 1 |
| Abdel-Razek, O; Di Santo, P; Fernando, SM; Froeschl, M; Hibbert, B; Jung, RG; Kapur, NK; Labinaz, M; Marbach, JA; Mathew, R; Parlow, S; Simard, T; Thayer, KL | 1 |
1 review(s) available for milrinone and lactic acid
| Article | Year |
|---|---|
What Inotrope and Why?
Topics: Cardiac Output; Cardiotonic Agents; Dobutamine; Dopamine; Echocardiography; Epinephrine; Heart; Humans; Hypotension; Infant, Newborn; Lactic Acid; Milrinone; Norepinephrine; Perfusion Index; Skin; Spectroscopy, Near-Infrared; Ultrasonography; Urination; Vasopressins | 2020 |
5 trial(s) available for milrinone and lactic acid
| Article | Year |
|---|---|
Markers of splanchnic perfusion and intestinal translocation of endotoxins during cardiopulmonary bypass: effects of dopamine and milrinone.
Topics: Adult; Aged; Biological Transport; Cardiopulmonary Bypass; Dopamine; Endotoxemia; Endotoxins; Humans; Hydrogen-Ion Concentration; Intestinal Mucosa; Lactic Acid; Middle Aged; Milrinone; Prospective Studies; Pyruvic Acid; Splanchnic Circulation | 1999 |
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
Topics: Blood Pressure; Cardiac Output, Low; Child; Child, Preschool; Double-Blind Method; Endpoint Determination; Female; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Lactic Acid; Male; Milrinone; Oxygen; Syndrome | 2003 |
The effect of milrinone on metabolism after cardiopulmonary bypass.
Topics: Acid-Base Equilibrium; Acidosis; Adult; Aged; Blood Glucose; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Epinephrine; Female; Hemodynamics; Humans; Infusions, Parenteral; Lactic Acid; Male; Middle Aged; Milrinone; Prospective Studies; Time Factors; Treatment Outcome; Vasodilator Agents | 2008 |
Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide.
Topics: Administration, Inhalation; Bronchodilator Agents; Cardiac Output; Echocardiography; Half-Life; Humans; Hypertension, Pulmonary; Infant, Newborn; Lactic Acid; Metabolic Clearance Rate; Milrinone; Nitric Oxide; Oxygen; Partial Pressure; Phosphodiesterase 3 Inhibitors; Pulmonary Artery; Treatment Outcome | 2013 |
Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial.
Topics: Dobutamine; Hospital Mortality; Humans; Lactic Acid; Milrinone; Shock, Cardiogenic | 2022 |
11 other study(ies) available for milrinone and lactic acid
| Article | Year |
|---|---|
The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle.
Topics: Age Factors; Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Cyclic AMP; Dogs; Heart; Lactates; Lactic Acid; Milrinone; Myocardial Contraction; Pyridones; Time Factors | 1986 |
Direct and indirect assessment of skeletal muscle blood flow in chronic congestive heart failure.
Topics: Captopril; Cardiac Output; Heart Failure; Humans; Lactates; Lactic Acid; Milrinone; Muscles; Phosphodiesterase Inhibitors; Physical Exertion; Pyridones; Regional Blood Flow; Thermodilution; Xenon Radioisotopes | 1988 |
Treating metabolic impairment and myocardial stunning with phosphodiesterase inhibitor type III, milrinone, administered prior to coronary artery occlusion in the presence of calcium channel blockade in pigs.
Topics: Analysis of Variance; Animals; Biomarkers; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Cardiotonic Agents; Coronary Stenosis; Diltiazem; Disease Models, Animal; Heart Rate; Lactic Acid; Milrinone; Myocardial Contraction; Myocardial Reperfusion; Myocardial Stunning; Phosphodiesterase Inhibitors; Research Design; Swine; Time Factors; Vascular Resistance; Ventricular Function, Left; Ventricular Pressure | 2007 |
Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and myocardial stunning in pigs.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary Stenosis; Disease Models, Animal; Heart Rate; Lactic Acid; Milrinone; Myocardial Reperfusion; Myocardial Stunning; Propanolamines; Random Allocation; Swine; Time Factors; Vascular Resistance; Ventricular Dysfunction, Left | 2008 |
Intestinal hemodynamic effects of milrinone in asphyxiated newborn pigs after reoxygenation with 100% oxygen: a dose-response study.
Topics: Animals; Animals, Newborn; Asphyxia Neonatorum; Cardiotonic Agents; Dose-Response Relationship, Drug; Glutathione; Humans; Infant, Newborn; Intestinal Mucosa; Intestines; Lactic Acid; Mesenteric Artery, Superior; Milrinone; Myocardial Contraction; Oxygen; Swine; Time Factors; Vascular Resistance; Vasoconstriction; Vasodilation | 2009 |
Novel modification of an artificial placenta: pumpless arteriovenous extracorporeal life support in a premature lamb model.
Topics: Animals; Arterial Pressure; Artificial Organs; Disease Models, Animal; Dopamine; Equipment Design; Extracorporeal Membrane Oxygenation; Female; Gestational Age; Lactic Acid; Milrinone; Placenta; Placental Circulation; Pregnancy; Premature Birth; Sheep; Time Factors; Vasoconstrictor Agents; Vasodilator Agents | 2012 |
Metabolic effects of three different inotropic strategies in the newborn piglet myocardium.
Topics: Animals; Animals, Newborn; Cardiotonic Agents; Dobutamine; Dopamine; Epinephrine; Hemodynamics; Lactic Acid; Microdialysis; Milrinone; Myocardium; Pyruvic Acid; Swine | 2013 |
Minimally invasive monitoring of skeletal muscle hypermetabolism induced by the phosphodiesterase-III-inhibitor milrinone and sodium fluoride.
Topics: Animals; Calcium Signaling; Drug Synergism; Enzyme Inhibitors; Extracellular Fluid; GTP-Binding Proteins; Hindlimb; Kinetics; Lactic Acid; Male; Microdialysis; Milrinone; Muscle, Skeletal; Perfusion; Phosphodiesterase 3 Inhibitors; Rats; Rats, Sprague-Dawley; Sodium Fluoride | 2013 |
Sustained release of milrinone delivered via microparticles in a rodent model of myocardial infarction.
Topics: Animals; Blood Pressure; Cardiotonic Agents; Cell Adhesion Molecules; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cytokines; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Female; Heart Failure; Heart Rate; Inflammation Mediators; Injections, Intravenous; Lactic Acid; Microspheres; Milrinone; Myocardial Infarction; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Inbred Lew; Solubility; Stroke Volume; Ventricular Function, Left | 2014 |
Effect of milrinone therapy on splanchnic perfusion after heart transplantation.
Topics: Adult; Alanine Transaminase; Amylases; Aspartate Aminotransferases; Cardiotonic Agents; Female; Glomerular Filtration Rate; Heart Transplantation; Humans; Lactic Acid; Male; Middle Aged; Milrinone; Phosphodiesterase 3 Inhibitors; Splanchnic Circulation | 2014 |
Phosphodiesterase Inhibitor-Based Vasodilation Improves Oxygen Delivery and Clinical Outcomes Following Stage 1 Palliation.
Topics: Blalock-Taussig Procedure; Cardiopulmonary Resuscitation; Extracorporeal Membrane Oxygenation; Female; Heart Arrest; Humans; Hypoplastic Left Heart Syndrome; Infant, Newborn; Lactic Acid; Male; Milrinone; Oxygen Consumption; Oxyhemoglobins; Palliative Care; Perioperative Care; Phosphodiesterase 3 Inhibitors; Postoperative Complications; Vascular Resistance | 2016 |